Pfizer Asks Approval for Vaccinations of 12 to 15 Year Old Children

Pfizer today is asking the US Food and Drug Administration to approve its Covid-19 vaccine for 12 to 15 year old children. Currently it is approved for anyone 16 or older. This comes after its trials showed it to be 100% effective in preventing Covid in that age group. Pfizer/BioNTech said they will also seek approval in other nations. Moderna and J&J are also conducting trials for young people.

www.cnn.com/…
Pfizer on Friday asked the FDA for an amendment to its emergency use authorization of its Covid-19 vaccine to expand its use in people ages 12-15 in the United States.
“It’s highly likely” that the FDA will allow the expansion and could act “relatively quickly,” the acting chairman of an FDA vaccine advisory committee said.

“It’s highly likely, if the data submitted support it,” said Dr. Arnold Monto, a professor of epidemiology at the University of Michigan who is serving as acting chairman of the advisory committee for its review of the Covid-19 vaccines. “I think it could be done relatively quickly.”

Meanwhile, nearly 4 million Americans received a vaccine dose yesterday, according to the CDC. About 34.5% of all US residents have been given at least one jab. Some 44.1% of US adults have received at least one injection, and 77.4% of Americans 65 or older have gotten a shot in the arm.

We are closing on one half the US adult population with an increase of 0.8% counted as getting their first shot on Thursday.

————————————

covid.cdc.gov/… Graph

US Vaccinations by Age

75> 77.0%

65-74 77.5%

50-64 49.6%

40-49 36.6%

30-39 30.6%

29-18 21.2%

<18 0.9%

www.msn.com/… Johnson and Johnson is still committed to delivery of 100 million vaccine doses to the US by May 31.

Looking for a vaccination appointment?

How are vaccinations going in your county?

www.washingtonpost.com/…

Bloomberg’s Vaccination Tracker

www.bloomberg.com/…

COVID.CDC.GOV/… COVID-19 VACCINATIONS IN US
Day		Delivered	Total Shots	1st Shot (% of Pop)	Fully Vac. (% of Pop)
4/8	Thu	233,591,955	178,837,781 +3,958,065	114,436,039 (34.5%) +2,389,428	68,202,458 (20.5%)
4/7	Wed	229,398,685	174,879,716 +3,403,061	112,046,611 (33.7%) +2,050,877	66,203,123 (19.9%)
4/6	Tue	225,294,435	171,476,655 +2,884,580	109,995,734 (33.1%) +1,694,500	64,422,618 (19.4%)
4/5	Mon	219,194,215	168,592,075 +1,404,280	108,301,234 (32.6%) +785,806	63,016,976 (19.0%)
4/4	Sun	207,891,395	167,187,795 +2,134,049	107,515,428 (32.4%) +1,300,504	62,392,065 (18.8%)
4/3	Sat	207,891,295	165,053,746 +3,365,324	106,214,924 (32.0%) +2,001,446	61,416,536 (18.5%)
4/2	Fri	207,866,645	161,688,422 +4,081,959	104,213,478 (31.4%) +2,408,716	59,858,146 (18%)
4/1	Thu	204,719,335	157,606,463 +3,975,059	101,804,762 (30.7%) +2,239,451	57,878,778 (17.5%)
3/31	Wed	200,496,635	153,631,404 +3,358,112	99,565,311 (30%) +1,972,021	56,089,614 (16.9%)
3/30	Tue	195,581,725	150,273,292 +2,670,947	97,593,290 (29.4%) +1,549,244	54,607,041 (16.4%)
3/29	Mon	189,451,285	147,602,345 +1,789,510	96,044,046 (28.9%) +1,357,858	53,423,486 (16.1%)
3/28	Sun	180,646,565	145,812,835 +2,350,144	94,686,188 (28.6) +1,055,025	52,529,949 (15.8%)
3/27	Sat	180,646,465	143,462,691 +3,281,956	93,631,163 (28.2%) +1,923,434	51,593,564 (15.5%)
3/26	Fri	180,644,125	140,180,735 +3,496,047	91,707,729 (27.6%) +2,148,504	50,141,769 (15.1%)
3/25	Thu	177,501,775	136,684,688 +3,379,393	89,559,225 (27%) +2,215,603	48,695,172 (14.7%)
3/24	Wed	173,525,335	133,305,295 +2,831,442	87,343,622 (26.3%) +1,871,456	47,350,657 (14.3%)
3/23	Tue	169,223,125	130,473,853 +2,256,824	85,472,166 (25.7%) +1,541,671	46,365,515 (14%)
2/27		J&J vaccine	authorized
1/19 12/18 12/14		pre-Biden Moderna Pfizer/Bio	20,110,911 authorized authorized